The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence of PI3K pathway aberrations and their impact on response to neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC) subtypes.
 
Reva K Basho
Employment - Castlewood Treatment Center (I); DaVita (I)
Honoraria - InSightec; Navigant Consulting
Consulting or Advisory Role - HERON; Puma Biotechnology
 
Alex Trevarton
No Relationships to Disclose
 
Kenneth R. Hess
No Relationships to Disclose
 
Chunxiao Fu
No Relationships to Disclose
 
Rosanna Lau
No Relationships to Disclose
 
Chih-Hsu Lin
No Relationships to Disclose
 
Olivier Lichtarge
No Relationships to Disclose
 
Wei Tse Yang
Honoraria - Wolters Kluwer
Consulting or Advisory Role - GE Healthcare; GE Healthcare; Seno Medical; Seno Medical
Patents, Royalties, Other Intellectual Property - Elsevier; Elsevier
 
William Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; ISIS Pharmaceuticals; Nuvera Biosciences
Consulting or Advisory Role - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Intellectual property
Travel, Accommodations, Expenses - Luminex
 
Stacy L. Moulder
Honoraria - Novartis
Research Funding - Bayer (Inst); Genentech (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Novartis